The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does a food intervention makes abiraterone treatment affordable?
 
Nielka P. Van Erp
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Ipsen (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Guillemette Emma Benoist
No Relationships to Disclose
 
Winald R. Gerritsen
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Sanofi (Inst)
Speakers' Bureau - Bayer; Merck Sharp & Dohme
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Genzyme; Janssen-Cilag; MSD Oncology; Roche; Roche
Speakers' Bureau - Roche
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Roche
 
David Burger
No Relationships to Disclose
 
Paul Hamberg
No Relationships to Disclose
 
Inge van Oort
No Relationships to Disclose
 
Floor Lubberman
No Relationships to Disclose